Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The balance of biogenic amines as condition for normal behaviour.

× No keyword cloud information.

37 in total

1. On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric method.

Authors: N E ANDEN; B E ROOS; B WERDINIUS
Journal: Life Sci (1962) Date: 1963-07

2. L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice.

Authors: G M Everett; J W Borcherding
Journal: Science Date: 1970-05-15 Impact factor: 47.728

3. Tryptophan in the treatment of depression.

Authors: A Coppen; D M Shaw; B Herzberg; R Maggs
Journal: Lancet Date: 1967-12-02 Impact factor: 79.321

4. [Experimental findings and new aspects in extrapyramidal diseases].

Authors: W Birkmayer
Journal: Wien Z Nervenheilkd Grenzgeb Date: 1966

5. [10 years of L-DOPA therapy of Parkinson's syndrome].

Authors: W Birkmayer
Journal: Wien Klin Wochenschr Date: 1971-04-02 Impact factor: 1.704

6. Modification of Parkinsonism--chronic treatment with L-dopa.

Authors: G C Cotzias; P S Papavasiliou; R Gellene
Journal: N Engl J Med Date: 1969-02-13 Impact factor: 91.245

7. Effect of L-DOPA on depression.

Authors: W E Bunney; D S Janowsky; F K Goodwin; J M Davis; H K Brodie; D L Murphy; T N Chase
Journal: Lancet Date: 1969-04-26 Impact factor: 79.321

8. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.

Authors: M D Muenter
Journal: Neurology Date: 1970-12 Impact factor: 9.910

9. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.

Authors: W H Timberlake
Journal: Neurology Date: 1970-12 Impact factor: 9.910

10. L-Dopa-induced release of cerebral monoamines.

Authors: K Y Ng; T N Chase; R W Colburn; I J Kopin
Journal: Science Date: 1970-10-02 Impact factor: 47.728

11 in total

1. Diagnostic aspects of early Parkinson's disease.

Authors: Thomas Müller; Gerd Fuchs; Matthias Hahne; Wolfgang Klein; Michael Schwarz
Journal: J Neurol Date: 2006-08 Impact factor: 4.849

2. L-Tryptophan: Biochemical, nutritional and pharmacological aspects.

Authors: E L Sainio; K Pulkki; S N Young
Journal: Amino Acids Date: 1996-03 Impact factor: 3.520

3. Brain-noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's syndrome.

Authors: P Riederer; W Birkmayer; D Seemann; S Wuketich
Journal: J Neural Transm Date: 1977 Impact factor: 3.575

Review 4. Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data.

Authors: B Scholtissen; F R J Verhey; H W M Steinbusch; A F G Leentjens
Journal: J Neural Transm (Vienna) Date: 2005-10-27 Impact factor: 3.575

Review 5. [Modern treatment of parkinsonism].

Authors: W Birkmayer; E Neumayer
Journal: Z Neurol Date: 1972

9. Rapid development of oedema and defective brain histidine metabolism in young guinea pigs fed protein-energy deficient diet.

Authors: C O Enwonwu; G O Okadigbo
Journal: Br J Exp Pathol Date: 1983-10

10. Biochemical post-mortem findings in depressed patients.

Authors: W Birkmayer; P Riederer
Journal: J Neural Transm Date: 1975 Impact factor: 3.575

The balance of biogenic amines as condition for normal behaviour.